Claus Munck Petersen

Oral and intravenous acyclovir are equally effective in herpes zoster

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • N A Peterslund, Denmark
  • V Esmann
  • ,
  • John Hjorth Ipsen
  • ,
  • K D Christensen
  • ,
  • C M Petersen
In a double-blind randomised trial 40 patients above 60 years old with acute herpes zoster received either 5 mg/kg acyclovir three times daily intravenously or 400 mg acyclovir five times daily orally for five days. Identical results were obtained with respect to duration of pain and rate of healing. Twenty per cent of orally administered acyclovir was absorbed and gave satisfactory concentrations of acyclovir in the vesicular fluid.
Original languageEnglish
JournalJournal of Antimicrobial Chemotherapy
Volume14
Issue2
Pages (from-to)185-9
Number of pages5
ISSN0305-7453
Publication statusPublished - 1984

    Research areas

  • Acyclovir, Administration, Oral, Aged, Clinical Trials as Topic, Double-Blind Method, Female, Herpes Zoster, Humans, Injections, Intravenous, Male, Pain, Random Allocation

See relations at Aarhus University Citationformats

ID: 43917199